Novel disubstituted 6-aminoquinazolinones of the Formula ##STR1## are useful as angiotensin-II receptor (subtype 2) antagonists (AT.sub.2 antagonists) alone or in combination with heparin, and can act to suppress the vascular stenosis which commonly occurs during the development of atherosclerosis and the restenosis following arterial angioplasty, stent placement, bypass surgery, heart transplantation or endarterectomy.
新型二取代
6-氨基喹唑啉酮的
化学式为##STR1##,可作为抗肾素II受体(亚型2)拮抗剂(AT.sub.2拮抗剂)单独使用或与
肝素结合使用,可抑制在动脉粥样硬化发展过程中常见的血管狭窄以及在动脉血管成形术、支架植入术、旁路手术、心脏移植或动脉内膜切除术后常见的再狭窄。